Drugs and the Vasculature Flashcards

1
Q

Hypertension is classified as

A

raised blood pressure 140/90mmHg.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How does Angiotensin II promote salt and water retention,

A

via the stimulation of aldosterone secretion, which promotes sodium retention by binding to the kidneys mineralocorticoid receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How does Angiotensin II promote increased BP

A

causes strong vasoconstriction via the AT1 receptor.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What stimulates renin secretion

A

renal perfusion pressure falling and sodium reabsorption falling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What cells stimulate renin secretion

A

sympathetic nervous system on JGA cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

MOA of aldosterone?

A

Aldosterone causes sodium reabsorption and water retention

Aldosterone passes through the cell membrane and binds to the intracellular mineralocorticoid receptor

It then upregulates the production of sodium channels and the production of Na+/K+ ATPase

The presence of more Na+/K+ ATPase means that you get more sodium reabsorption
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

uses of ACEi

A
Hypertension
	Heart failure
	Post-MI
	Diabetic nephropathy
	Progressive renal insufficiency
•	Patients at high risk of cerebrovascular disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is enalapril

A

An ACEi

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Example of an ACEi

A

Enalapril

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What does ACEi do

A

Inhibit the somatic form of angiotensin converting enzyme (ACE)
Prevent the conversion of angiotensin I to angiotensin II by ACE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Effect of ACEi?

A

ACE inhibitors reduce the AT1 dependent vasoconstriction leading to a fall in TPR and a fall in blood pressure

It also reduces the production of aldosterone meaning that you get a decrease in blood volume and a decrease in venous return
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How do ACEi effect cardiac output

A

It also reduces the production of aldosterone (which retains water and Na) meaning that you get a decrease in blood volume and a decrease in venous return

The venous return is also linked, by Starling's Law, to contractility (and cardiac output)

Reduced venous return reduces the cardiac output because of the decrease in preload 

So as anti‐hypertensives, ACE inhibitors have an effect on TPR and cardiac output
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What do AT receptor blockers do?

A

Antagonists of receptors for ATII

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Main unwanted effect of ACEi? Why?

A

Cough because it prevents the breakdown of bradykinin which causes cough

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Unwanted effects of ACEi (4)

A

Cough, hypotension, hyperkalaemia, renal failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

how does ACEi cause hyperkalaemia

A

because there is less sodium reuptake and less potassium excretion. Aldosterone promotes insertion of Na channels and NaK ATPase into kidney cells to promote Na moving from the tubule into the blood. If you block AT1 receptor, or block ACE, less aldosterone and so fewer of these proteins in the membrane. This means that there is an increased K in the blood as it isn’t lost in the urine. Also may cause hyponatraemia.

17
Q

How can ACEi cause renal failure

A

You get poor flow into the glomerulus with poor pressure so GFR isn’t great. ATII one of its roles is to constrict the efferent arteriole and so increase the pressure in the glomerulus. But if you give patients ACEI or ARB you lose the ability to constrict the efferent arteriole so low pressure in glomerulus, GFR goes down, renal failure carries on from there.

18
Q

Dihydropyridines AKA

A

Non-rate limiting

19
Q

Dihydropyridines were more powerful on va. SM or cardiac SM?

A

va. SM

20
Q

Are dihydropyridines/non-dyhydropyridine OR rate-limiting/non-rate limiting CCBs used more for hypertension

A

Dihydropyridines/ non-rate limiting bc they don’t limit heart rate

21
Q

Are CCBs lipid soluble

A

Not very

22
Q

Where do CCBs act

A

extracellular surface of the protein

23
Q

What do DHP do regarding Ca

A

inhibit calcium entry into vascular smooth muscle cells

24
Q

What can the decreased blood pressure due to DHP cause

A

reflex tachycardia

25
Q

What effect can vasodilators have on myocardial oxygen demand and why

A

powerful vasodilators can lead to reflex tachycardia and increased inotropy thus increased myocardial oxygen demand

26
Q

Why give anyone over 55 or Afro Caribbean CCBs or thiazide diuretic

A

these groups tend to have low renin hypertension. This means that their plasma renin is low relevant to aldosterone and ATII levels, and because of this an ACEI doesn’t have the same effect

27
Q

where do BB have their main effect

A

Heart

28
Q

Why have BBs been removed as first line treatment for hypertension

A

Reduction in TPR has the most profound effect on blood pressure and beta blockers have their main effect on the heart

29
Q

Why are alpha blockers used as antihypertensives

A

If you block the alpha 1 receptor in vasculature you get profound vasodilation and a drop in total peripheral resistance

30
Q

Problem with with alpha blockers?

A

Selectivity, you need a relatively selective alpha‐1 blocker because the alpha-2 receptor is the negative feedback receptor for the SNS
you need a relatively selective alpha‐1 blocker because the alpha-2 receptor is the negative feedback receptor for the SNS

31
Q

what is spironolactone

A

Aldosterone Antagonist

32
Q

An Aldosterone Antagonist ?

A

Spironolactone

33
Q

3 main treatments for cardiac failure

A

ACE Inhibitors
Beta Blockers
Angiotensin Receptor Blockers